N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer

NCT05445882 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Closed by study team, no subjects enrolled.

Conditions

Castration Resistant Prostate Cancer

Interventions

DRUG: Bintrafusp alfa
DRUG: N-803
BIOLOGICAL: BN-Brachyury

Sponsor

National Cancer Institute (NCI)